| |
| | Business With Disease |
 | | MARKEY: It would be a problem because people, in many instances, because they know they have these illnesses, will pay anything and they should know as soon as possible that the drug is not effective, because then they, with their physician, might be able to construct some other strategy. |
 | | MARKEY: They could be taking something else, and moreover, there is no requirement by the FDA that this conditional approval be put on the label. |
 | | MARKEY: Well, I think that if each patient and physician understood that the approval for the drug was only conditional, not permanent, that that would put real pressure on the FDA and the drug company to complete all of the tests as quickly as possible. |
| www.drrathresearch.org /health_news/bwd_060305_mainstream.html (989 words) |
|